TTRX Turn Therapeutics, Inc.
Turn Therapeutics, Inc. (TTRX) is expected to report earnings on February 8, 2027, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of -7.8% since its last earnings release on November 9, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Turn Therapeutics, Inc.
Turn Therapeutics is a clinical-stage biotechnology company developing next-generation dermatology, wound and anti-infective therapies. Turn Therapeutics is based in WESTLAKE VILLAGE, Calif.
Charts powered in part by Lightweight Charts™ by TradingView.